Silvano Gnesin

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Swiss survey and national diagnostic reference levels for PET/CT examinations in adults.

Swiss survey and national diagnostic reference levels for PET/CT examinations in adults.

Journal: Zeitschrift fur medizinische Physik

Published: May 07, 2026

Image quality and lesion detectability in simulated [124I]MIBG cardiac imaging across 3-generation PET/CT scanners using a phantom model: Implications for activity and acquisition time reduction in clinical practice.

Image quality and lesion detectability in simulated [124I]MIBG cardiac imaging across 3-generation PET/CT scanners using a phantom model: Implications for activity and acquisition time reduction in clinical practice.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 04, 2026

Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs.

Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 08, 2025

Biodistribution and radiation dosimetry of 82Rb at rest and under adenosine stress in the paediatric population.

Biodistribution and radiation dosimetry of 82Rb at rest and under adenosine stress in the paediatric population.

Journal: EJNMMI research

Published: April 22, 2025

Rethinking Dosimetry: A European Perspective.

Rethinking Dosimetry: A European Perspective.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 21, 2024

Discordance between 90Y-PET/CT(MR)-estimated activity and dose calibrator measured administered activity: an international study in SIRT patients treated with resin and glass microspheres.

Discordance between 90Y-PET/CT(MR)-estimated activity and dose calibrator measured administered activity: an international study in SIRT patients treated with resin and glass microspheres.

Journal: EJNMMI physics

Published: November 05, 2024

Lung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening.

Lung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 04, 2024

Superselective Intra-Arterial Lutetium-177 Prostate-Specific Membrane Antigen Therapy for Localized Nodal Metastasis in Prostate Cancer: A Case Report.

Superselective Intra-Arterial Lutetium-177 Prostate-Specific Membrane Antigen Therapy for Localized Nodal Metastasis in Prostate Cancer: A Case Report.

Journal: Journal of vascular and interventional radiology : JVIR

Published: October 10, 2024

Do we need dosimetry for the optimization of theranostics in CNS tumors?

Do we need dosimetry for the optimization of theranostics in CNS tumors?

Journal: Neuro-oncology

Published: October 01, 2024

Measure of 90Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison 99mTc-MAA SPECT/CT dosimetry.

Measure of 90Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison 99mTc-MAA SPECT/CT dosimetry.

Journal: EJNMMI reports

Published: March 20, 2024

Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours.

Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours.

Journal: EJNMMI physics

Published: February 27, 2024

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 29, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026